Effect of Gestational Diabetes Mellitus on Pregnancy Outcomes Among Younger and Older Women and Its Additive Interaction with Advanced Maternal Age

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 May 26

PMID 37234802

Authors

Jiangheng Li

Jingli Yan

Linghua Ma

Yongquan Huang

Maoling Zhu

Wu Jiang

Affiliations

Soon will be listed here.

Abstract

Background: The prevalence of gestational diabetes mellitus (GDM) and advanced maternal age (AMA, ≥ 35 years) has shown an increasing trend worldwide. This study aimed to evaluate the risk of pregnancy outcomes among younger (20-34 years) and older (≥ 35 years) women with GDM and further analyze the epidemiologic interaction of GDM and AMA on these outcomes.

Methods: This historical cohort study included 105 683 singleton pregnant women aged 20 years or older between January 2012 and December 2015 in China. Stratified by maternal age, the associations between GDM and pregnancy outcomes were analyzed by performing logistic regression. Epidemiologic interactions were assessed by using relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (SI) with their 95% confidence intervals (95%CIs).

Results: Among younger women, individuals with GDM had a higher risk of all maternal outcomes, preterm birth (relative risk [RR] 1.67, 95%CI 1.50-1.85), low birthweight (RR 1.24, 95%CI 1.09-1.41), large for gestational age (RR 1.51, 95%CI 1.40-1.63), macrosomia (RR 1.54, 95%CI 1.31-1.79), and fetal distress (RR 1.56, 95%CI 1.37-1.77) than those without GDM. Among older women, GDM increased the risk of gestational hypertension (RR 2.17, 95%CI 1.65-2.83), preeclampsia (RR 2.30, 95%CI 1.81-2.93), polyhydramnios (RR 3.46, 95%CI 2.01-5.96), cesarean delivery (RR 1.18, 95%CI 1.10-1.25), preterm birth (RR 1.35, 95%CI 1.14-1.60), large for gestational age (RR 1.40, 95%CI 1.23-1.60), macrosomia (RR 1.65, 95%CI 1.28-2.14) and fetal distress (RR 1.46, 95%CI 1.12-1.90). Additive interactions of GDM and AMA on polyhydramnios and preeclampsia were found, with RERI of 3.11 (95%CI 0.05-6.16) and 1.43 (95%CI 0.09-2.77), AP of 0.51 (95%CI 0.22-0.80) and 0.27 (95%CI 0.07-0.46), and SI of 2.59 (95%CI 1.17-5.77) and 1.49 (95%CI 1.07-2.07), respectively.

Conclusion: GDM is an independent risk factor for multiple adverse pregnancy outcomes, and may exert additive interactions with AMA on the risk of polyhydramnios and preeclampsia.

Citing Articles

The Role of Placental MFF-Mediated Mitochondrial Fission in Gestational Diabetes Mellitus.

Wei L, Fang C, Jiang Y, Zhang H, Gao P, Zhou X Diabetes Metab Syndr Obes. 2025; 18:541-554.

PMID: 39995822 PMC: 11849531. DOI: 10.2147/DMSO.S484002.

Influence of parity on weight gain during pregnancy in women with Gestational Diabetes: A retrospective cohort study.

Lin L, Chen R, Lin H, Yao T, Chen Z, Zheng L Pak J Med Sci. 2025; 41(1):29-36.

PMID: 39867753 PMC: 11755282. DOI: 10.12669/pjms.41.1.11412.

Predictive value of placental growth factor level for adverse pregnancy outcome in twin pregnancies at advanced maternal age.

Du L, Wang B, Zhang M, Bai J, Xu X, Wang N Am J Transl Res. 2024; 16(11):6581-6592.

PMID: 39678615 PMC: 11645630. DOI: 10.62347/NFCD8953.

Construction and validation of a novel nomogram for predicting spontaneous preterm birth in patients with gestational diabetes mellitus.

Zhu J, Xie Y Am J Transl Res. 2024; 16(10):5466-5476.

PMID: 39544809 PMC: 11558387. DOI: 10.62347/MQQF2601.

References

Jenabi E, Salimi Z, Bashirian S, Khazaei S, Ayubi E . The risk factors associated with placenta previa: An umbrella review. Placenta. 2021; 117:21-27. DOI: 10.1016/j.placenta.2021.10.009. View

Redfield M, Rodeheffer R, Jacobsen S, Mahoney D, Bailey K, Burnett Jr J . Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002; 40(5):976-82. DOI: 10.1016/s0735-1097(02)02059-4. View

Sweeting A, Ross G, Hyett J, Molyneaux L, Constantino M, Harding A . Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment. Diabetes Care. 2015; 39(1):75-81. DOI: 10.2337/dc15-0433. View

Reinders P, Zoellner Y, Schneider U . Real-world evaluation of adverse pregnancy outcomes in women with gestational diabetes mellitus in the German health care system. Prim Care Diabetes. 2020; 14(6):633-638. DOI: 10.1016/j.pcd.2020.04.009. View

Jiang M, Mishu M, Lu D, Yin X . A case control study of risk factors and neonatal outcomes of preterm birth. Taiwan J Obstet Gynecol. 2018; 57(6):814-818. DOI: 10.1016/j.tjog.2018.10.008. View

Laopaiboon M, Lumbiganon P, Intarut N, Mori R, Ganchimeg T, Vogel J . Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG. 2014; 121 Suppl 1:49-56. DOI: 10.1111/1471-0528.12659. View

Metzger B, Gabbe S, Persson B, Buchanan T, Catalano P, Damm P . International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3):676-82. PMC: 2827530. DOI: 10.2337/dc09-1848. View

Wang C, Tong M, Zhang J, Yu J, Meng W, Jin L . Prevalence of gestational diabetes mellitus and its determinants among pregnant women in Beijing. J Matern Fetal Neonatal Med. 2020; 35(7):1337-1343. DOI: 10.1080/14767058.2020.1754395. View

Zhuang W, Lv J, Liang Q, Chen W, Zhang S, Sun X . Adverse effects of gestational diabetes-related risk factors on pregnancy outcomes and intervention measures. Exp Ther Med. 2020; 20(4):3361-3367. PMC: 7444321. DOI: 10.3892/etm.2020.9050. View

10.

Rao K, Belogolovkin V, Yankowitz J, Spinnato 2nd J . Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa. Obstet Gynecol Surv. 2012; 67(8):503-19. DOI: 10.1097/OGX.0b013e3182685870. View

11.

Muche A, Olayemi O, Gete Y . Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia. BMC Pregnancy Childbirth. 2020; 20(1):73. PMC: 6998275. DOI: 10.1186/s12884-020-2759-8. View

12.

Kc K, Shakya S, Zhang H . Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015; 66 Suppl 2:14-20. DOI: 10.1159/000371628. View

13.

Yang X, Hsu-Hage B, Zhang H, Yu L, Dong L, Li J . Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care. 2002; 25(5):847-51. DOI: 10.2337/diacare.25.5.847. View

14.

Deng L, Ning B, Yang H . Association between gestational diabetes mellitus and adverse obstetric outcomes among women with advanced maternal age: A retrospective cohort study. Medicine (Baltimore). 2022; 101(40):e30588. PMC: 9542683. DOI: 10.1097/MD.0000000000030588. View

15.

Lowe S, Brown M, Dekker G, Gatt S, McLintock C, McMahon L . Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009; 49(3):242-6. DOI: 10.1111/j.1479-828X.2009.01003.x. View

16.

Schmidt C, Kohlmann T . When to use the odds ratio or the relative risk?. Int J Public Health. 2009; 53(3):165-7. DOI: 10.1007/s00038-008-7068-3. View

17.

Hosmer D, Lemeshow S . Confidence interval estimation of interaction. Epidemiology. 1992; 3(5):452-6. DOI: 10.1097/00001648-199209000-00012. View

18.

Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L . IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria. Diabetes Res Clin Pract. 2021; 183:109050. DOI: 10.1016/j.diabres.2021.109050. View

19.

Wang X, Zhang X, Zhou M, Juan J, Wang X . Association of Gestational Diabetes Mellitus with Adverse Pregnancy Outcomes and Its Interaction with Maternal Age in Chinese Urban Women. J Diabetes Res. 2021; 2021:5516937. PMC: 8154302. DOI: 10.1155/2021/5516937. View

20.

Negrato C, Jovanovic L, Tambascia M, Geloneze B, Dias A, Calderon I . Association between insulin resistance, glucose intolerance, and hypertension in pregnancy. Metab Syndr Relat Disord. 2008; 7(1):53-9. DOI: 10.1089/met.2008.0043. View